We recently compiled a list of the 15 Buzzing AI Stocks Making Headlines. In this article, we are going to take a look at ...

RBC Capital analyst Christopher Dendrinos lowered the firm’s price target on Fluence Energy (FLNC) to $27 from $28 and keeps ...

RBC Capital analyst Luca Issi maintained a Hold rating on Moderna (MRNA – Research Report) on November 25 and set a price target of $50.00. The ...

Lower interest rates could prod Canadian banks into a mortgage competition next year as the cost of borrowing drops and ...

RBC Capital analyst Michael Siperco maintained a Hold rating on Equinox Gold (EQX – Research Report) on November 25 and set a price target of C$10.00. The company’s shares closed yesterday at $5.60.

Demand for options protection against an equity market crash is rising, even as a post-election rally takes U.S. stocks to ...

Extendicare Inc. has received a target price upgrade from RBC Capital Markets (Analyst Rank#3), which raised its price target to CAD 11 from CAD 9.50. The revision comes on the back of the company’s ...

As an investment banking associate at RBC Capital Markets, MBA graduate Emmanuel Fadahunsi is helping his clients drive ...

Strategists see falling inflation, resilient economic growth, and rising earnings driving further returns for the S&P 500 in ...

Tariffs have taken the spotlight as a policy issue as S&P 500 companies have discussed earnings with analysts since the U.S.

Economists at AMP, ANZ and Bank of Queensland have joined a chorus of forecasters expecting rate cuts no sooner than May.